Meg M. McGilley
Nessuna posizione attualmente
Profilo
Meg M.
McGilley was the founder and had founded Somaxon Pharmaceuticals, Inc. in 2003, where she held the title of Chief Financial Officer, Treasurer & VP until 2009.
She was a Senior Finance Director at Women First HealthCare, Inc. from 1998 to 2000, Finance Director at LMA North America, Inc. and Gensia Automedics, Inc. in 1997-1998, and Chief Financial Officer at Instromedix, Inc. and LifeWatch Holdings, Inc. from 2000 to 2002.
Ms. McGilley received an undergraduate degree from the University of San Diego.
Precedenti posizioni note di Meg M. McGilley
| Società | Posizione | Fine |
|---|---|---|
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | Fondatore | 16/05/2009 |
Instromedix, Inc.
 Instromedix, Inc. Medical SpecialtiesHealth Technology Part of Koninklijke Philips NV, Instromedix, Inc. is an American company that manufactures portable cardiac event monitoring and pacemaker follow-up systems. The company is based in CA. The company was founded by Shirley L. Semler. Instromedix was acquired by Card Guard Scientific Survival Ltd from CareFusion 303, Inc. on August 31, 2000 for $30 million. | Direttore Finanziario/CFO | 01/01/2002 |
| LifeWatch Holdings, Inc. | Direttore Finanziario/CFO | 01/01/2002 |
Women First HealthCare, Inc.
 Women First HealthCare, Inc. Publishing: Books/MagazinesConsumer Services Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA. | Direttore Finanziario/CFO | 01/01/2000 |
| Gensia Automedics, Inc. | Direttore Finanziario/CFO | 01/01/1998 |
Formazione di Meg M. McGilley
| University of San Diego | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Women First HealthCare, Inc.
Women First HealthCare, Inc. Publishing: Books/MagazinesConsumer Services Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA. | Consumer Services |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | Health Technology |
Instromedix, Inc.
Instromedix, Inc. Medical SpecialtiesHealth Technology Part of Koninklijke Philips NV, Instromedix, Inc. is an American company that manufactures portable cardiac event monitoring and pacemaker follow-up systems. The company is based in CA. The company was founded by Shirley L. Semler. Instromedix was acquired by Card Guard Scientific Survival Ltd from CareFusion 303, Inc. on August 31, 2000 for $30 million. | Health Technology |
LMA North America, Inc.
 LMA North America, Inc. Medical DistributorsDistribution Services Part of Teleflex, Inc., LMA North America, Inc. distributes medical and hospital equipment. The company is based in San Diego, CA. | Distribution Services |
| Gensia Automedics, Inc. | |
| LifeWatch Holdings, Inc. |
- Borsa valori
- Insiders
- Meg M. McGilley
